gliclazide has been researched along with deoxyglucose in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fantus, IG; Klip, A; Leiter, LA; Ramlal, T; Tsiani, E | 1 |
| Akaoka, L; Funato, H; Kawasaki, T; Miyashita, H; Ogata, N; Sekino, N; Tagaya, T; Yamanouchi, T | 1 |
| Iwamoto, Y; Ohta, M; Wasada, T; Yano, T; Yui, N | 1 |
| Eto, S; Hashimoto, O; Imamur, H; Kanda, K; Morimoto, I; Tanaka, Y; Yamashita, S | 1 |
| Dey, CS; Kumar, N | 1 |
| Araki, A; Sasamoto, K; Shirabe, S; Yamanouchi, T; Yanagawa, T | 1 |
| Kawamori, R; Miwa, S; Ohmura, C; Tanaka, Y; Watada, H | 1 |
| Chalmers, J; Cooper, ME; Hamet, P; Harrap, S; Juraschek, SP; Lazo, M; Marre, M; McEvoy, JW; Selvin, E; Wang, D; Williams, B; Woodward, M | 1 |
4 trial(s) available for gliclazide and deoxyglucose
| Article | Year |
|---|---|
Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Evaluation Studies as Topic; Female; Follow-Up Studies; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Isomerism; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Time Factors | 1996 |
Effect of antidiabetic medications on microalbuminuria in patients with type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Cholesterol; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Thiazolidinediones | 2004 |
Efficacy and safety of once daily gliclazide (20 mg/day) compared with nateglinide.
Topics: Adult; Cross-Over Studies; Cyclohexanes; Deoxyglucose; Diabetes Mellitus, Type 2; Gliclazide; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Malondialdehyde; Nateglinide; Phenylalanine; Prospective Studies; Serum Albumin; Thiobarbituric Acid Reactive Substances | 2004 |
Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Intention to Treat Analysis; Male; Microvessels; Middle Aged; Perindopril; Proportional Hazards Models; Risk Factors; Treatment Outcome | 2019 |
4 other study(ies) available for gliclazide and deoxyglucose
| Article | Year |
|---|---|
Stimulation of glucose uptake and increased plasma membrane content of glucose transporters in L6 skeletal muscle cells by the sulfonylureas gliclazide and glyburide.
Topics: Animals; Biological Transport, Active; Cell Line; Cell Membrane; Cycloheximide; Deoxyglucose; Dose-Response Relationship, Drug; Gliclazide; Glucose; Glyburide; Insulin; Kinetics; Monosaccharide Transport Proteins; Muscle, Skeletal; Rats; Tissue Distribution | 1995 |
ATP-Sensitive potassium channels modulate glucose transport in cultured human skeletal muscle cells.
Topics: 3-O-Methylglucose; Adenosine Triphosphate; Benzopyrans; Biological Transport; Cells, Cultured; Cyclopentanes; Deoxyglucose; Enzyme Activation; Gliclazide; Glucose; Glyburide; Humans; Hypoglycemic Agents; Insulin; Ion Channel Gating; Muscle, Skeletal; Nicorandil; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Tetradecanoylphorbol Acetate | 2001 |
Regulation of glucose transporter 1 expression by gliclazide in rat L6 myoblasts.
Topics: Animals; Biological Transport; Cell Line; Cyclic AMP-Dependent Protein Kinases; Deoxyglucose; Enzyme Inhibitors; Gene Expression Regulation; Gliclazide; Glucose Transporter Type 1; Hypoglycemic Agents; Monosaccharide Transport Proteins; Muscles; Rats; RNA, Messenger; Tritium | 2001 |
Gliclazide increases insulin receptor tyrosine phosphorylation but not p38 phosphorylation in insulin-resistant skeletal muscle cells.
Topics: Animals; Cell Line; Deoxyglucose; Enzyme Inhibitors; Gliclazide; Hypoglycemic Agents; Imidazoles; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mice; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Muscle, Skeletal; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Pyridines; Receptor, Insulin; Signal Transduction; Tyrosine | 2002 |